sulfo-SPDB-DM4 is a novel drug-linker conjugate used in antibody-drug conjugates (ADCs) in which the cytotoxic tubuin inhibitor maytansinebased (DM4) is employed via the sulfo-SPDB linker as the warhead for killing cancer cells.